APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

leflunomide, Quantity: 20 mg

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

Leflunomide

Lyfjaform:

Tablet, uncoated

Samsetning:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

Stjórnsýsluleið:

Oral

Einingar í pakka:

30 tablets

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Vörulýsing:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Leyfisstaða:

Licence status A

Leyfisdagur:

2011-07-22